Marapharm Ventures Inc. 'Marapharm' Announces it's Been Added to the United States Marijuana Index
PR Newswire PR NewswireApril 19, 2017
KELOWNA, British Columbia, April 19, 2017 /PRNewswire/ --
Marapharm (MRPHF) has been added (source: forbes.com) to the United States Marijuana Index (marijuanaindex.com). The North American Marijuana Index, composed from the United States Marijuana Index and the Canadian Marijuana Index, tracks the leading cannabis stocks listed on North American stock exchanges. The North American Marijuana Index level in April 2016 was 50 and in April 2017 the index level is 150, an increase of approximately 200%. In order for a company to be in the Index the criteria includes having a weighted average minimum market daily trading volume of $600,000.
A stock market index is a measurement of the value of a section of the stock market. It is computed from the prices of selected stocks. It is a tool used by investors and financial managers to describe the market and to compare the return of specific investments.
"Marapharm is pleased to be part of this important index which is the voice of credibility for the rapid development of the marijuana sector. We are executing on our plans, by bringing the Nevada facility into production, capitalizing on the real estate acquisition in Washington, have property and permits in California and will continue to look for additional opportunities for cultivation and production licenses and facilities in the United States. In addition, our investment in Veritas Pharma continues to provide synergy and our investment has more than doubled in value within 3 months," Linda Sampson, Marapharm CEO.
